AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « plasma »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
plaques < plasma < plasmablast  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]
Ident.Authors (with country if any)Title
000070 (2016) Janet S. Lee [États-Unis] ; M. John Chapman [France] ; Paolo Piraino [Italie] ; Jens Lamerz [Suisse] ; Thomas Schindler [Suisse] ; Paul Cutler [Suisse] ; Gregor Dernick [Suisse]Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin‐6 receptor‐alpha inhibition with tocilizumab
000073 (2013) Györgyi M Zes [Hongrie] ; Ferenc Sipos [Hongrie] ; Judit Csomor [Hongrie] ; Lídia Sréter [Hongrie]Successful tocilizumab treatment in a patient with human herpesvirus 8‐positive and human immunodeficiency virus‐negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab‐CVP therapy
000169 (2015) Yanli Zhuang [États-Unis] ; Dick E. De Vries [Pays-Bas] ; Zhenhua Xu [États-Unis] ; Stanley J. Marciniak Jr. [États-Unis] ; Dion Chen [États-Unis] ; Francisco Leon [États-Unis] ; Hugh M. Davis [États-Unis] ; Honghui Zhou [États-Unis]Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach
000234 (2012) G. Lippi [Italie] ; G. Targher [Italie]Optimal therapy for reduction of lipoprotein(a)
000240 (2013) Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon]Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
000314 (2010) Ukihide Tateishi [Japon] ; Tomoyuki Imagawa [Japon] ; Noriko Kanezawa [Japon] ; Tetsuhiko Okabe [Japon] ; Kazuya Shizukuishi [Japon] ; Tomio Inoue [Japon] ; Shumpei Yokota [Japon]PET assessment of disease activity in children with juvenile idiopathic arthritis
000463 (2010) Luis Rodríguez-Rodríguez [Espagne] ; José Ram N Lamas [Espagne] ; Jezabel Varadé [Espagne] ; Pedro L Pez-Romero [Espagne] ; Pilar Tornero-Esteban [Espagne] ; Lydia Abasolo [Espagne] ; Emilio Gomez De La Concha [Espagne] ; Juan Angel Jover [Espagne] ; Elena Urcelay [Espagne] ; Benjamín Fernández-Gutiérrez [Espagne]Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity
000659 (2013) T. Matsutani ; Y. Li ; M. Murakami ; H.-M. Lee ; C. Aoki ; M. Sekiguchi ; K. Matsui ; M. Kitano ; M. Namiki ; K. Ohmura [Japon] ; K. Murakami [Japon] ; T. Fujii [Japon] ; T. Kuroiwa ; Y. Shimaoka ; H. Nakahara ; K. Maeda ; S. Irimajiri ; M. Funauchi ; Y. Imura ; T. Ikawa ; A. Nanpei ; T. Azuma ; T. Sasaki ; A. Yokota ; Y. Kawahito [Japon] ; T. Mimori [Japon] ; H. Sano ; N. NishimotoFRI0206 Abatacept (CTLA4-IG) suppresses T cell activation and reduces TH17 cells as well as plasma IL-6 in patients with rheumatoid arthritis
000714 (2014) Haruyo Iwadate [Japon] ; Hiroko Kobayashi [Japon] ; Takashi Kanno [Japon] ; Tomoyuki Asano [Japon] ; Rie Saito [Japon] ; Shuzo Sato [Japon] ; Eiji Suzuki [Japon] ; Hiroshi Watanabe [Japon] ; Hiromasa Ohira [Japon]Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients
000861 (2013) Takaaki Ogoshi [Japon] ; Takashi Kido [Japon] ; Kazuhiro Yatera [Japon] ; Keishi Oda [Japon] ; Toshinori Kawanami [Japon] ; Hiroshi Ishimoto [Japon] ; Noriho Sakamoto [Japon] ; Arisa Sano [Japon] ; Chiharu Yoshii [Japon] ; Shohei Shimajiri [Japon] ; Hiroshi Mukae [Japon]Assessment of Pathologically Diagnosed Patients with Castleman’s Disease associated with Diffuse Parenchymal Lung Involvement Using the Diagnostic Criteria for IgG4-Related Disease
000A60 (2007) J. Neuhaus [Allemagne] ; N. Schlichting [Allemagne] ; A. Oberbach [Allemagne] ; J.-U. Stolzenburg [Allemagne]Regulation von Interleukin-6 durch Lipopolysaccharid-Stimulation in kultivierten humanen Detrusormyozyten
000B11 (2009) Dario Tomasini [Italie] ; Clementina Zampatti [Italie] ; Giovanni Serio [Italie]Castleman’s disease with numerous mantle zone lymphocytes with clear cytoplasm involving the skin: case report
000C11 (2013) E. Ball [Canada] ; A. Bell ; M. Rooney [Royaume-Uni]THU0314 Plasma IL-6 Levels Correlate with Ultrasound Measures of Disease Activity in Lupus Arthritis
000C88 (2011) Chao Rong [République populaire de Chine] ; Wei Hu [République populaire de Chine] ; Fan-Rong Wu [République populaire de Chine] ; Xiao-Juan Cao [République populaire de Chine] ; Fei-Hu Chen [République populaire de Chine]Interleukin-23 as a potential therapeutic target for rheumatoid arthritis
000C98 (2012) Krzysztof Kanecki [Pologne] ; Piotr Tyszko [Pologne] ; Małgorzata Wisłowska [Pologne] ; Justyna Łyczkowska-Piotrowska [Pologne]Preliminary report on a study of health-related quality of life in patients with rheumatoid arthritis
000E09 (2012) Frantisek Drafi [Slovaquie] ; Katarina Bauerova [Slovaquie] ; Viera Kuncirova [Slovaquie] ; Silvester Ponist [Slovaquie] ; Danica Mihalova [Slovaquie] ; Tatiana Fedorova [Russie] ; Juraj Harmatha [République tchèque] ; Radomir Nosal [Slovaquie]Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate
000E30 (2012) Isabella Ellinger [Autriche] ; Renate Fuchs [Autriche]HFcRn-mediated transplacental immunoglobulin G transport: Protection of and threat to the human fetus and newborn
000E53 (2013) Marina Kacevska [Australie] ; Andre Mahns [Australie] ; Rohini Sharma [Australie, Royaume-Uni] ; Stephen J. Clarke [Australie] ; Graham R. Robertson [Australie] ; Christopher Liddle [Australie]Extra-Hepatic Cancer Represses Hepatic Drug Metabolism Via Interleukin (IL)-6 Signalling
000F69 (2011) T. Burnouf [France]Recombinant plasma proteins
000F70 (2016) Michael Low [Australie] ; Simona Infantino [Australie] ; George Grigoriadis [Australie] ; David Tarlinton [Australie, États-Unis]Targeting plasma cells: are we any closer to a panacea for diseases of antibody‐secreting cells?
001075 (2013) Y. J. Ha ; J.-S. Song [Corée du Sud] ; E.-J. Kang ; K. H. Lee ; S. T. Choi [Corée du Sud]AB0198 Plasma leucine-rich alpha-2 glycoprotein is a useful disease activity biomarker in rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "plasma" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "plasma" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    plasma
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021